Navigation Links
Barr Reports Second Quarter 2008 GAAP Earnings of $0.52 Per Share; Adjusted Earnings of $0.64 Per Share
Date:8/7/2008

g sales growth in this product in the second half of 2008 while we remain the only generic available on the U.S. market. Our SEASONIQUE(R) extended-cycle oral contraceptive and the PARAGARD(R) IUC were the principal drivers in higher proprietary product sales year-over-year."

"The strength of our generic and proprietary product portfolios, our commercial strength in important global markets, and our focus on delivering sound results are among the benefits that make the proposed acquisition of Barr by Teva, announced on July 18th, so attractive. Management is committed to continuing to deliver strong performance as the acquisition process progresses, to ensure that at the close of the transaction, the capabilities of Barr will significantly complement Teva's existing business," Downey continued.

Revenues

Generic Product Sales

The Company's generic product sales were $557 million for the second quarter of 2008, compared to $484 million in the prior year period. For the first six months of 2008, generic product sales were $1.0 billion, compared to $956 million for the prior year period. A discussion of the Company's generic product sales for the second quarter of 2008 compared to the prior year period is presented below.

North American

Sales of North American generic products totaled $340 million for the

second quarter of 2008, compared to $296 million in the prior year period.

The increase in sales is primarily related to higher sales of generic oral

contraceptives.

Sales of generic oral contraceptives increased 34% to $155 million in the

second quarter of 2008, up from $116 million in the prior year period.

The increase primarily reflects sales of Ocella(TM), the Company's generic

Yasmin(R) oral contraceptive product that was launched at the end of the

second quarter of 2008, which more than offset lower volume and pricing on

several other oral contraceptive
'/>"/>

SOURCE Barr Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related biology technology :

1. PAREXEL Reports Fourth Quarter and Fiscal Year 2008 Financial Results
2. Caliper Life Sciences Reports Second Quarter 2008 Results
3. Watson Pharmaceuticals Reports Second Quarter 2008 Results
4. EntreMed Reports Second Quarter 2008 Financial Results
5. Transgenomic Reports Second Quarter 2008 Results
6. Onyx Pharmaceuticals Reports Second Quarter and Six-Month 2008 Financial Results
7. Bionovo Reports Second Quarter 2008 Financial Results
8. AtriCure Reports Record Second Quarter 2008 Financial Results
9. AMICAS Reports Financial Results for the Second Quarter Ended June 30, 2008
10. eResearchTechnology Reports Second Quarter 2008 Results
11. SuperGen Reports 2008 Second Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... December 23, 2014 On Friday, ... H.R. 83, the Omnibus and Continuing Resolution Appropriations ... made hydrocephalus a condition eligible to receive funding ... administered by the Department of Defense (DoD). The ... allies on Capitol Hill, is celebrating this victory ...
(Date:12/24/2014)... (PRWEB) December 24, 2014 The report ... at 19.7% by 2019. It also provides a carefully ... strategies and challenges for the market. , Full Copy ... the report, the global market for cell expansion will ... future. It expects this growth to be driven by ...
(Date:12/24/2014)... -- PharmaBoardroom,s new report, , Healthcare ... for free download , digs deep into this vibrant ... the sector today. One area where ... developing a homegrown pharmaceutical manufacturing base, even if the government,s ... way off. A cursory comparison with neighboring Morocco ...
(Date:12/22/2014)... 22, 2014 The Center for ... of technical training across the life sciences industry, has ... (SCDM) to provide the organization's members with discounted ... access to the more than 350 sessions across 80 ... 10% off when registering for a public course ...
Breaking Biology Technology:Rare Brain Condition Now Eligible for Department of Defense Research Dollars 2The Cell Expansion Market is Expected to Reach $14.8 billion by 2019 - New Research Report by MarketsandMarkets 2The Cell Expansion Market is Expected to Reach $14.8 billion by 2019 - New Research Report by MarketsandMarkets 3PharmaBoardroom Releases New Algeria Pharmaceuticals Report 2PharmaBoardroom Releases New Algeria Pharmaceuticals Report 3CfPIE Announces Partnership with the Society for Clinical Data Management 2CfPIE Announces Partnership with the Society for Clinical Data Management 3
... - FDA Targets January 11, 2008 as Action Date, ... SPPI ) today announced that the amendment to,the ... LFA),for injection has been accepted by the U.S. Food ... 2008 as its action date regarding,the approval of the ...
... Asset Exchange Agreement, COPENHAGEN, September 13 ... an asset exchange agreement with,Medarex, Inc. Under the ... to HuMax-Inflam(TM)/MDX-018, which targets IL-8, and Medarex will,receive ... Genmab and,Medarex will release to each other all ...
... UPTON, NY Scientists at the U.S. Department of ... for controlling the self-assembly of nanometer and micrometer-sized particles. ... a particles surface, can be used to manipulate the ... of numerous materials that may be of interest ...
Cached Biology Technology:FDA Accepts ISO-Vorin(TM) New Drug Application Amendment Submitted by Spectrum Pharmaceuticals 2FDA Accepts ISO-Vorin(TM) New Drug Application Amendment Submitted by Spectrum Pharmaceuticals 3Genmab Announces Asset Exchange Agreement 2New DNA-based technique for assembly of nano- and micro-sized particles 2
(Date:12/10/2014)... , Dec. 9, 2014 CIE San ... catalyst that provides the connective tissue that enhances care ... them to easily share client-level information; earned a second ... expand to organizations serving seniors aging in community and; ... partner on December 11 th 4-6p. ...
(Date:12/10/2014)... 9, 2014     ...   Jifflenow, a ... solutions for business-to-business (B2B) events, today announced a ... mobile near-field communication (NFC), Bluetooth low energy (BLE), ... http://photos.prnewswire.com/prnh/20140612/691055) , Jifflenow will integrate its ...
(Date:12/5/2014)... -- Tute Genomics, a leader in cloud-based solutions for genome ... led by UK-based Eurovestech. Peak Ventures and a number ... "We are at a pivotal time in ... seeks new approaches for the diagnosis, treatment and prevention ... and CEO of Tute Genomics. "One of the main ...
Breaking Biology News(10 mins):Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 3Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 4Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 2Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 3Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 2Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 3
... say they have discovered a cause-and-effect relationship between ... believed to be independent of one another. ... better drugs to treat the cognitive dysfunction associated ... ,Researchers have long studied the role played in ...
... Rice University and Lockheed Martin reported this month that ... from a single silicon wafer. The process uses simple ... lithium-ion batteries, laying the groundwork for longer-lasting, more powerful ... vehicles. The work led by Sibani Lisa Biswal, ...
... up their arms, clench their fists and grimace after a ... the same across cultures, a new study suggests. New findings ... Human Behavior suggest this victory pose signals feelings of ... "We found that displays of triumph include different behaviors ...
Cached Biology News:Johns Hopkins researchers link 2 biological risk factors for schizophrenia 2Toughened silicon sponges may make tenacious batteries 2Victory stance may be a universal gesture of triumph -- not pride -- study suggests 2
Ultra-sensitive, non-radioactive detection of rat Osteopontin...
Request Info...
Agarose-LE, 500 g. Suitable for soft agarose cloning. Nuclease-free.Gel point (1.5%): 36 1.5 C, EEO (-mr): 1200 g/cm2. Category: Nucleotides & Enzymes & Biochemicals, Ultrapure Biochemicals ....
Request Info...
Biology Products: